Dynavax Co-founder Takes Long View on Vaccine Development
Xconomy
DECEMBER 4, 2017
9 announcement , the price of Dynavax shares slipped about 8 percent, from $20.05 For Dennis Carson, however, the FDA announcement represented the culmination of a scientific odyssey that took 21 years. Many investors sold stock on the news. In the days following the company’s Nov. a share to $18.45
75 
Let's personalize your content